Search - tctmd.com

Displaying 41 - 60 of 80

Sort: Relevancy | Date

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

News Conference News AHA 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

November 14, 2020

Fish Oil, Vitamin D Don’t Prevent A-fib: VITAL Rhythm

News Conference News AHA 2020

Fish Oil, Vitamin D Don’t Prevent A-fib: VITAL Rhythm

November 13, 2020

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

News Daily News

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

Michael O'Riordan

October 02, 2020

Got Mail? Letter-Based Intervention Doesn’t Boost OAC Initiation for A-fib

News Conference News ESC 2020

Got Mail? Letter-Based Intervention Doesn’t Boost OAC Initiation for A-fib

September 03, 2020

Updated ESC A-fib Guidance Proposes New Path for Diagnosis, Classification, and Care

News Conference News ESC 2020

Updated ESC A-fib Guidance Proposes New Path for Diagnosis, Classification, and Care

August 30, 2020

Arrhythmias in COVID-19: New Review Tackles Mechanisms, Management

News Daily News

Arrhythmias in COVID-19: New Review Tackles Mechanisms, Management

August 13, 2020

More Evidence of Lower Fracture Risk With DOACs Versus Warfarin

News Daily News

More Evidence of Lower Fracture Risk With DOACs Versus Warfarin

May 19, 2020

‘Silent’ Brain Infarcts Common, Tied to Cognitive Decline in A-fib

News Daily News HRS 2020

‘Silent’ Brain Infarcts Common, Tied to Cognitive Decline in A-fib

May 14, 2020

A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI

News Conference News ACC 2020

A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI

March 29, 2020

Low Mortality Rates Seen With Andexanet Alfa for Factor Xa-Related Bleeds

News Conference News ACC 2020

Low Mortality Rates Seen With Andexanet Alfa for Factor Xa-Related Bleeds

March 25, 2020

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

September 11, 2019

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

News Conference News ESC 2019

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

September 03, 2019

Increasing Oral Anticoagulation Use Tied to Less Ischemic Stroke in A-fib Patients in Italy

News Conference News ESC 2019

Increasing Oral Anticoagulation Use Tied to Less Ischemic Stroke in A-fib Patients in Italy

August 31, 2019

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

News Conference News ESC Heart Failure 2019

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

May 26, 2019

Even in the DOAC Era, Women Less Likely Than Men to Receive Anticoagulation for A-fib

News Conference News HRS 2019

Even in the DOAC Era, Women Less Likely Than Men to Receive Anticoagulation for A-fib

May 17, 2019

Coping With CABANA: Despite Trial Flaws, A-fib Experts Say Lessons Have Been Learned

News Conference News EHRA 2019

Coping With CABANA: Despite Trial Flaws, A-fib Experts Say Lessons Have Been Learned

March 26, 2019

Long-Awaited CABANA Publication Arrives, With Accompanying Quality-of-Life Study

News Daily News

Long-Awaited CABANA Publication Arrives, With Accompanying Quality-of-Life Study

March 15, 2019

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

News Daily News

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

March 12, 2019

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

News Daily News

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

February 01, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.